Oseltamivir Phosphate with at Least a 10-year Shelf Life

Delivery order 75A50325F80003 was awarded under the authority of a Limited Source Justification pursuant to FAR 8.405-6(a)(1)(i)(B), only one source is capable of providing the supplies required at the level or quality required because the supplies or services are unique or highly specialized for the supply of oseltamivir phosphate with at least a 10-year shelf life. The NAICS code for this procurement is 325412, Pharmaceutical and Preparation Manufacturing.

Period of performance – from date of award for 24 months thereafter. The Administration for Strategic Preparedness and Response, Center for the Strategic National Stockpile (SNS) awarded a firm fixed-price delivery order to Genentech USA, Inc., located at 1 DNA Way, South San Francisco, CA 94080-4918. This delivery order was awarded to replace expiring Tamiflu (oseltamivir phosphate) 30mg and 75mg capsules with long shelf-life oseltamivir phosphate 30mg and 75mg capsules with at least a 10-year shelf-life.

Replacement ensures that the SNS maintains its stockpile of Influenza antivirals that have long-term stability and potency, and that remain deployable and available for an emergency without any additional procurement or government-funded drug stability studies. Oseltamivir phosphate is an antiviral medication primarily used to treat acute Influenza A and B in patients experiencing symptoms for less than 48 hours.

Oseltamivir phosphate works by inhibiting a key enzyme necessary for viral replication, reducing the severity and duration of flu symptoms, facilitating faster recovery, and offering preventative benefits when exposure to the virus occurs.